血清乳酸水平升高是脓毒症相关急性肾损伤发生及死亡的独立危险因素
该回顾性队列研究纳入两家医院ICU共655例脓毒症患者,按入ICU 24小时内乳酸水平四分位分组,比较脓毒症相关急性肾损伤(AKI)发生率和院内死亡率。随着乳酸水平升高,AKI发生率(Q1-Q4分别为34.5%、41.0%、58.4%、66.3%)和院内死亡率(23.4%、29.2%、33.1%、43.4%)均逐渐升高(均P<0.01)。多因素Logistic回归显示乳酸升高是脓毒症相关AKI发生(OR=1.096,95%CI 1.022-1.175,P=0.010)及院内死亡(OR=1.074,95%CI 1.004-1.149,P=0.037)的独立危险因素。ROC曲线显示乳酸预测AKI发生和死亡的AUC分别为0.653(95%CI 0.611-0.694)和0.593(95%CI 0.530-0.656,均P<0.01),cut-off值分别为2.75 mmol/L和5.95 mmol/L。
要点
- 脓毒症患者入ICU 24小时内乳酸≥2.75 mmol/L时,脓毒症相关AKI风险是乳酸<2.75 mmol/L者的2.772倍(OR=2.772,95%CI 1.754-4.380,P<0.001)。
- 脓毒症相关AKI患者乳酸≥5.95 mmol/L时,院内死亡风险是乳酸<5.95 mmol/L者的2.511倍(OR=2.511,95%CI 1.378-4.574,P=0.003)。
- 调整性别、感染部位、血管活性药物、基线机械通气、MAP、基线肾功能不全、尿酸、PCT、PLT、基线SCr和基线eGFR等因素后,乳酸升高仍是脓毒症相关AKI发生的独立危险因素(OR=1.096,95%CI 1.022-1.175,P=0.010)。
- 调整年龄、糖尿病、血管活性药物、基线eGFR等因素后,乳酸升高仍是脓毒症相关AKI患者院内死亡的独立危险因素(OR=1.074,95%CI 1.004-1.149,P=0.037)。
- 乳酸预测脓毒症相关AKI发生的AUC为0.653(95%CI 0.611-0.694),cut-off值2.75 mmol/L时敏感度57.8%、特异度69.2%;预测死亡的AUC为0.593(95%CI 0.530-0.656),cut-off值5.95 mmol/L时敏感度56.7%、特异度83.7%。
适用人群与场景
- 2014年3月至2019年6月广西医科大学第一附属医院内科ICU及2017年1月至2020年6月广西医科大学第二附属医院ICU收治的脓毒症患者,共655例。
诊断标准与关键阈值
- 根据入ICU 24小时内血清乳酸水平四分位分组:Q1组≤1.4 mmol/L,Q2组1.5-2.4 mmol/L,Q3组2.5-4.0 mmol/L,Q4组≥4.1 mmol/L。
- 乳酸预测脓毒症相关AKI发生的cut-off值为2.75 mmol/L(敏感度57.8%,特异度69.2%)。
- 乳酸预测脓毒症相关AKI患者院内死亡的cut-off值为5.95 mmol/L(敏感度56.7%,特异度83.7%)。
研究设计与关键结果
- 回顾性队列研究,纳入655例脓毒症患者,其中330例(50.4%)发生AKI,325例(49.6%)未发生AKI;330例脓毒症相关AKI患者中134例(40.6%)死亡,196例(59.4%)存活。
- 随乳酸水平升高(Q1-Q4组),脓毒症相关AKI发生率逐渐升高(分别为34.5%、41.0%、58.4%、66.3%),院内死亡率也逐渐升高(分别为23.4%、29.2%、33.1%、43.4%),差异均有统计学意义(均P<0.01)。
- 与未发生AKI组比较,AKI组乳酸水平显著升高[mmol/L:3.08(1.84,5.70)比1.91(1.20,3.10),P<0.01]。
- 调整性别(男性)、感染部位(腹腔)、血管活性药物、基线机械通气、平均动脉压(MAP)、基线肾功能不全、尿酸、降钙素原(PCT)、血小板计数(PLT)、基线血清肌酐(SCr)和基线估算肾小球滤过率(eGFR)等因素后,多因素Logistic回归分析显示乳酸升高是脓毒症相关AKI的独立危险因素(OR=1.096,95%CI 1.022-1.175,P=0.010)。
- 与存活组比较,死亡组乳酸水平显著升高[mmol/L:3.55(2.00,6.76)比3.00(1.70,4.50),P<0.01]。
- 调整年龄、糖尿病、血管活性药物、基线eGFR等因素后,多因素Logistic回归分析提示乳酸升高是脓毒症相关AKI患者院内死亡的独立危险因素(OR=1.074,95%CI 1.004-1.149,P=0.037)。
- ROC曲线分析显示,乳酸预测脓毒症相关AKI发生和死亡的AUC分别为0.653(95%CI 0.611-0.694)和0.593(95%CI 0.530-0.656,均P<0.01)。
- 乳酸≥2.75 mmol/L时,脓毒症相关AKI风险是乳酸<2.75 mmol/L者的2.772倍(OR=2.772,95%CI 1.754-4.380,P<0.001);乳酸≥5.95 mmol/L时,脓毒症相关AKI患者院内死亡风险是乳酸<5.95 mmol/L者的2.511倍(OR=2.511,95%CI 1.378-4.574,P=0.003)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于脓毒症患者,入ICU 24小时内乳酸≥2.75 mmol/L提示脓毒症相关AKI风险增加,乳酸≥5.95 mmol/L提示脓毒症相关AKI患者院内死亡风险增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore the effect of serum lactic acid (Lac) level on acute kidney injury (AKI) in patients with sepsis and whether Lac level affects the in-hospital mortality of patients with sepsis-associated AKI.
METHODS: A retrospective cohort study was conducted. Clinical data of patients with sepsis admitted to the internal intensive care unit (ICU) of the First Affiliated Hospital of Guangxi Medical University from March 2014 to June 2019 and the ICU of the Second Affiliated Hospital of Guangxi Medical University from January 2017 to June 2020 were collected. According to the first quartile of Lac within 24 hours of admission to ICU, the patients were divided into Lac ≤ 1.4 mmol/L group (group Q1), Lac 1.5-2.4 mmol/L group (group Q2), Lac 2.5-4.0 mmol/L group (group Q3), and Lac ≥ 4.1 mmol/L group (group Q4). The incidence of sepsis-associated AKI after admission to ICU and hospital mortality were compared among four groups. The effect of elevated Lac on the incidence and mortality of sepsis-associated AKI was investigated by binary Logistic regression analysis. The receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of Lac on the incidence and mortality of sepsis-associated AKI, and the cut-off value was obtained to analyze the incidence and death risk of sepsis-associated AKI at different Lac levels.
RESULTS: A total of 655 sepsis patients were enrolled, of which 330 patients (50.4%) developed AKI and 325 patients (49.6%) did not. Among 330 patients with sepsis-associated AKI, 134 (40.6%) died and 196 (59.4%) survived. With the increase of Lac level, the incidence of sepsis-associated AKI increased gradually (34.5%, 41.0%, 58.4%, 66.3%, respectively, in group Q1-Q4), meanwhile, the in-hospital mortality also increased gradually (23.4%, 29.2%, 33.1%, 43.4%, respectively, in group Q1-Q4), the differences were statistically significant (both P < 0.01). Compared with the non-AKI group, the Lac level in the AKI group was significantly increased [mmol/L: 3.08 (1.84, 5.70) vs. 1.91 (1.20, 3.10), P < 0.01]. After adjustment for factors such as gender (male), site of infection (abdominal cavity), vasoactive drugs, basal mechanical ventilation, mean arterial pressure (MAP), basal renal insufficiency, uric acid, procalcitonin (PCT), platelet count (PLT), basal serum creatinine (SCr) and basal estimated glomerular filtration rate (eGFR), and other influencing factors, multivariate Logistic regression analysis showed that elevated Lac was an independent risk factor for sepsis-associated AKI [odds ratio (OR) = 1.096, 95% confidence interval (95%CI) was 1.022-1.175, P = 0.010]. Compared with the survival group, the Lac level in the death group was significantly increased [mmol/L: 3.55 (2.00, 6.76) vs. 3.00 (1.70, 4.50), P < 0.01]. After adjusting for age, diabetes, vasoactive drugs, basal eGFR, and other factors, multivariate Logistic regression analysis suggested that increased Lac was an independent risk factor for in-hospital mortality in sepsis-associated AKI patients (OR = 1.074, 95%CI was 1.004-1.149, P = 0.037). ROC curve analysis showed that the area under the ROC curve (AUC) of Lac for predicting the incidence and mortality of sepsis-associated AKI was 0.653 (95%CI was 0.611-0.694) and 0.593 (95%CI was 0.530-0.656, both P < 0.01), respectively, and the cut-off values were 2.75 mmol/L (sensitivity was 57.8%, specificity was 69.2%) and 5.95 mmol/L (sensitivity was 56.7%, specificity was 83.7%). When the Lac ≥ 2.75 mmol/L, the risk of sepsis-associated AKI was 2.772 times higher than that of < 2.75 mmol/L (OR = 2.772, 95%CI was 1.754-4.380, P < 0.001). When the Lac ≥ 5.95 mmol/L, the patients with sepsis-associated AKI had a 2.511 times higher risk of in-hospital death than those with Lac < 5.95 mmol/L (OR = 2.511, 95%CI was 1.378-4.574, P = 0.003).
CONCLUSIONS: Elevated Lac level is an independent risk factor for the incidence and mortality of sepsis-associated AKI. When Lac ≥ 2.75 mmol/L, the risk of AKI in patients with sepsis increased by 1.772 times; when Lac ≥ 5.95 mmol/L, the risk of in-hospital death in patients with sepsis related AKI increased by 1.511 times.
参考来源
- Gong C, Jiang Y, Tang Y, et al. [Elevated serum lactic acid level is an independent risk factor for the incidence and mortality of sepsis-associated acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36100409. doi:10.3760/cma.j.cn121430-20210823-01238
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。